Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(14):1052-1053;
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Jones, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 14, 1052-1053, July 18, 2001
© 2001 Oxford University Press

NEWS

Bisphosphonates May Be Useful In Treatment of Bone Metastases

Jemarion Jones

Data from a new study suggest that the oral drug clodronate can delay the progression of symptoms related to bone metastases in patients with prostate cancer. The results have some researchers optimistic that a new compound will soon be added to the short list of treatment options for the 30% of prostate cancer patients who experience debilitating pain related to bone metastases.

In the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?